Bio View (XTAE:BIOV) PB Ratio : 1.41 (As of May. 27, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Bio View PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-27), Bio View's share price is ₪0.287. Bio View's Book Value per Share for the quarter that ended in Dec. 2023 was ₪0.20. Hence, Bio View's PB Ratio of today is 1.41.

The historical rank and industry rank for Bio View's PB Ratio or its related term are showing as below:

XTAE:BIOV' s PB Ratio Range Over the Past 10 Years
Min: 0.93 Med: 1.83 Max: 3.3
Current: 1.43

During the past 13 years, Bio View's highest PB Ratio was 3.30. The lowest was 0.93. And the median was 1.83.

XTAE:BIOV's PB Ratio is ranked better than
69.37% of 790 companies
in the Medical Devices & Instruments industry
Industry Median: 2.25 vs XTAE:BIOV: 1.43

During the past 3 years, the average Book Value Per Share Growth Rate was 4.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 5.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 4.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bio View was 19.20% per year. The lowest was -4.00% per year. And the median was 5.65% per year.

Back to Basics: PB Ratio

Bio View PB Ratio Historical Data

The historical data trend for Bio View's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio View PB Ratio Chart

Bio View Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

1.74

2.24

1.69

1.82

1.62

Bio View Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial															1.97	1.87	1.82	1.70	1.62

Competitive Comparison of Bio View's PB Ratio

For the Medical Devices subindustry, Bio View's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio View's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio View's PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio View's PB Ratio falls into.

Bio View PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Bio View's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	0.287	/	0.203
	=	1.41

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Bio View (XTAE:BIOV) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Bio View PB Ratio Related Terms

Thank you for viewing the detailed overview of Bio View's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio View (XTAE:BIOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio View Ltd (XTAE:BIOV) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Pekeris Street, Rehovot, ISR, 7670203

Website

http://www.bioview.co.il

Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.

Bio View (XTAE:BIOV) Headlines

No Headlines